×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NEO – neogenomics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NEO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/14
07:36 am
neo
NeoGenomics (NASDAQ:NEO) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Low
Report
NeoGenomics (NASDAQ:NEO) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
1/12
10:37 am
neo
NeoGenomics (NASDAQ:NEO) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $14.00 price target on the stock.
Low
Report
NeoGenomics (NASDAQ:NEO) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $14.00 price target on the stock.
1/12
07:48 am
neo
NeoGenomics sees Q4 revenue of about $190M [Seeking Alpha]
Medium
Report
NeoGenomics sees Q4 revenue of about $190M [Seeking Alpha]
1/12
07:20 am
neo
NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue [Yahoo! Finance]
Medium
Report
NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue [Yahoo! Finance]
1/12
07:05 am
neo
NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue
Medium
Report
NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue
1/7
10:58 am
neo
NeoGenomics (NASDAQ:NEO) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Low
Report
NeoGenomics (NASDAQ:NEO) had its "buy" rating reaffirmed by analysts at Cowen Inc.
1/6
02:33 pm
neo
A Look At NeoGenomics (NEO) Valuation After Recent Share Price Momentum Shift [Yahoo! Finance]
Low
Report
A Look At NeoGenomics (NEO) Valuation After Recent Share Price Momentum Shift [Yahoo! Finance]
1/5
07:40 am
neo
NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
1/15
04:23 pm
neo
Form 4 NEOGENOMICS INC For: Jan 13 Filed by: Stone Warren
Low
Report
Form 4 NEOGENOMICS INC For: Jan 13 Filed by: Stone Warren
1/15
04:22 pm
neo
Form 4 NEOGENOMICS INC For: Jan 13 Filed by: Olivo Alicia C
Low
Report
Form 4 NEOGENOMICS INC For: Jan 13 Filed by: Olivo Alicia C
1/12
07:10 am
neo
Form 8-K NEOGENOMICS INC For: Jan 09
Medium
Report
Form 8-K NEOGENOMICS INC For: Jan 09
1/5
06:16 pm
neo
Form 4 NEOGENOMICS INC For: Jan 01 Filed by: Kenny John P.
Medium
Report
Form 4 NEOGENOMICS INC For: Jan 01 Filed by: Kenny John P.
1/5
06:15 pm
neo
Form 3 NEOGENOMICS INC For: Jan 01 Filed by: Kenny John P.
Medium
Report
Form 3 NEOGENOMICS INC For: Jan 01 Filed by: Kenny John P.
12/30
07:08 am
neo
Form 8-K NEOGENOMICS INC For: Dec 23
Low
Report
Form 8-K NEOGENOMICS INC For: Dec 23
12/9
04:20 pm
neo
Form SCHEDULE 13G NEOGENOMICS INC Filed by: MILLENNIUM MANAGEMENT LLC
Low
Report
Form SCHEDULE 13G NEOGENOMICS INC Filed by: MILLENNIUM MANAGEMENT LLC
12/9
04:16 pm
neo
Form 4 NEOGENOMICS INC For: Dec 07 Filed by: Sherman Jeffrey Scott
Low
Report
Form 4 NEOGENOMICS INC For: Dec 07 Filed by: Sherman Jeffrey Scott
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/16
Form 4 NEOGENOMICS INC For: Mar 13 Filed by: JONES STEVEN C
14.5%
10/29 Q3/2019 9/30/2019 EPS 0.070 ZacksConsensus 0.040 ActVsEst 0.030 - Beat 11.0%
4/28 Neogenomics Inc (NEO) Q1 2020 Earnings Call Transcript [The Motley Fool] 10.9%
3/1 NeoGenomics, Inc. Just Beat EPS By 122%: Here's What Analysts Think Will Happen Next [Yahoo! Finance News] 5.9%
11/22 Form 4 NEOGENOMICS INC For: Nov 20 Filed by: JONES STEVEN C 5.2%
3/18 NeoGenomics, Inc. (NASDAQ: NEO) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 5.1%
2/27 NeoGenomics, Inc. (NEO) CEO Doug VanOort on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] 5.1%
2/28 NeoGenomics To Present At 41st Annual Raymond James Institutional Investor Conference 5.0%
5/22 Form 8-K NEOGENOMICS INC For: May 22 4.3%
10/3 NeoGenomics (NEO) Presents At Cantor Healthcare Conference - Slideshow [Seeking Alpha] 3.9%
10/29 Q3/2019 9/30/2019 EPS 0.070 ZacksConsensus 0.040 ActVsEst 0.030 - Beat 11.0%
4/28 Neogenomics Inc (NEO) Q1 2020 Earnings Call Transcript [The Motley Fool] 10.9%
3/1 NeoGenomics, Inc. Just Beat EPS By 122%: Here's What Analysts Think Will Happen Next [Yahoo! Finance News] 5.9%
11/22 Form 4 NEOGENOMICS INC For: Nov 20 Filed by: JONES STEVEN C 5.2%
3/18 NeoGenomics, Inc. (NASDAQ: NEO) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 5.1%
2/27 NeoGenomics, Inc. (NEO) CEO Doug VanOort on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] 5.1%
2/28 NeoGenomics To Present At 41st Annual Raymond James Institutional Investor Conference 5.0%
5/22 Form 8-K NEOGENOMICS INC For: May 22 4.3%
10/3 NeoGenomics (NEO) Presents At Cantor Healthcare Conference - Slideshow [Seeking Alpha] 3.9%
TOP News Decliners
4/29
NeoGenomics Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes
-13.0%
4/28 Form 8-K NEOGENOMICS INC For: Apr 28 -11.0%
4/3 NeoGenomics Integrates HALO(R) From Indica Labs -10.3%
2/27 Q4/2019 12/31/2019 EPS 0.100 ZacksConsensus 0.050 ActVsEst 0.050 - Beat -10.0%
4/21 NeoGenomics, Inc. (NASDAQ: NEO) is now covered by analysts at Stephens. They set an "overweight" rating on the stock. -6.7%
5/20 Form 8-K NEOGENOMICS INC For: May 20 -5.8%
10/30 NeoGenomics, Inc. (NASDAQ: NEO) had its price target raised by analysts at Needham & Company LLC from $27.00 to $29.00. They now have a "buy" rating on the stock. -5.6%
6/10 Form 4 NEOGENOMICS INC For: Jun 06 Filed by: Johnson Kevin C -5.3%
2/5 NeoGenomics Announces Leadership Appointments -5.2%
4/1 NeoGenomics Schedules its First Quarter Earnings Release for April 28, 2020 -4.8%
4/28 Form 8-K NEOGENOMICS INC For: Apr 28 -11.0%
4/3 NeoGenomics Integrates HALO(R) From Indica Labs -10.3%
2/27 Q4/2019 12/31/2019 EPS 0.100 ZacksConsensus 0.050 ActVsEst 0.050 - Beat -10.0%
4/21 NeoGenomics, Inc. (NASDAQ: NEO) is now covered by analysts at Stephens. They set an "overweight" rating on the stock. -6.7%
5/20 Form 8-K NEOGENOMICS INC For: May 20 -5.8%
10/30 NeoGenomics, Inc. (NASDAQ: NEO) had its price target raised by analysts at Needham & Company LLC from $27.00 to $29.00. They now have a "buy" rating on the stock. -5.6%
6/10 Form 4 NEOGENOMICS INC For: Jun 06 Filed by: Johnson Kevin C -5.3%
2/5 NeoGenomics Announces Leadership Appointments -5.2%
4/1 NeoGenomics Schedules its First Quarter Earnings Release for April 28, 2020 -4.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: